Market closedNon-fractional

Sanara MedTech/SMTI

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Sanara MedTech

Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.

Ticker

SMTI

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Fort Worth, United States

Employees

108

Sanara MedTech Metrics

BasicAdvanced
$232M
Market cap
-
P/E ratio
-$0.59
EPS
1.67
Beta
-
Dividend rate
$232M
1.67
1.348
0.945
24.166
27.202
-10.22%
-7.25%
-11.89%
3.294
5.13
-52.05
-65.851
26.98%
-21.18%
58.52%
-0.33%

What the Analysts think about Sanara MedTech

Analyst Ratings

Majority rating from 1 analysts.
Buy

Sanara MedTech Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-9.18% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$19M
5.11%
Net income
-$1.7M
750.00%
Profit margin
-9.18%
712.39%

Sanara MedTech Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 200.00%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.22
-$0.13
-$0.03
-$0.21
-
Expected
-$0.13
$0.00
-$0.13
-$0.07
-$0.21
Surprise
69.23%
-∞%
-76.92%
200.00%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Sanara MedTech stock?

Sanara MedTech (SMTI) has a market cap of $232M as of July 06, 2024.

What is the P/E ratio for Sanara MedTech stock?

The price to earnings (P/E) ratio for Sanara MedTech (SMTI) stock is 0 as of July 06, 2024.

Does Sanara MedTech stock pay dividends?

No, Sanara MedTech (SMTI) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next Sanara MedTech dividend payment date?

Sanara MedTech (SMTI) stock does not pay dividends to its shareholders.

What is the beta indicator for Sanara MedTech?

Sanara MedTech (SMTI) has a beta rating of 1.67. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Sanara MedTech stock

Buy or sell Sanara MedTech stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing